FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Assurance Infusion TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL Recall

TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800

Assurance Infusion · Houston, TX

Risk level
Class II
Reported by FDA
Jan 22, 2020
Recall ID
D-0776-2020
Check your lot numberHow we source this data

Summary

Assurance Infusion recalled TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL starting Dec 20, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0776-2020 on Jan 22, 2020. Reason: Lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of sterility assurance.

Product description

TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800

Lot numbers, UPCs & expiration codes

Lots: 08082019@7 Exp. 02/04/2020; 08232019@1 Exp. 02/19/2020; 07262019@12 Exp. 01/22/2020; 07012019@25 Exp. 12/28/2019; 07102019@14 Exp. 01/06/2020; 09202019@4 Exp. 03/18/2020; 10282019@23 Exp. 04/25/2020; 10092019@7 Exp. 03/04/2020; 08292019@11 Exp. 02/25/2020; 10042019@6 Exp. 04/01/2020; 10162019@20 Exp. 04/13/2020; 11062019@24 Exp. 03/04/2020; 12042019@20 Exp. 01/18/2020; 12102019@11 Exp. 01/24/2020; 12162019@36 Exp. 01/30/2020; 11262019@29 Exp. 01/10/2020

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0776-2020
Classification
Class II
Status
Terminated
Recall initiated
Dec 20, 2019
FDA report date
Jan 22, 2020
Quantity
358 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Assurance Infusion

Original FDA data

Every field from FDA enforcement report D-0776-2020, exactly as published.

Show all FDA fields
City
Houston
State
TX
Status
Terminated
Country
United States
Event ID
84546
Address
2626 S Loop W Ste 555
Code information
Lots: 08082019@7 Exp. 02/04/2020; 08232019@1 Exp. 02/19/2020; 07262019@12 Exp. 01/22/2020; 07012019@25 Exp. 12/28/2019; 07102019@14 Exp. 01/06/2020; 09202019@4 Exp. 03/18/2020; 10282019@23 Exp. 04/25/2020; 10092019@7 Exp. 03/04/2020; 08292019@11 Exp. 02/25/2020; 10042019@6 Exp. 04/01/2020; 10162019@20 Exp. 04/13/2020; 11062019@24 Exp. 03/04/2020; 12042019@20 Exp. 01/18/2020; 12102019@11 Exp. 01/24/2020; 12162019@36 Exp. 01/30/2020; 11262019@29 Exp. 01/10/2020
Postal code
77054-2652
Report date
Jan 22, 2020
Product type
Drugs
Recall number
D-0776-2020
Classification
Class II
Recalling firm
Assurance Infusion
Product quantity
358 vials
Termination date
Oct 27, 2021
Reason for recall
Lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800
Distribution pattern
Nationwide within the United States
Recall initiation date
Dec 20, 2019
Initial firm notification
Letter
Center classification date
Jan 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0776-2020, published Jan 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls